Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Precision medicine in inflammatory bowel disease: concept, progress and challenges
Simon Borg‐Bartolo, Ray Boyapati, Jack Satsangi, et al.
F1000Research (2020) Vol. 9, pp. 54-54
Open Access | Times Cited: 79

Showing 1-25 of 79 citing articles:

Helicobacter pylori infection: Beyond gastric manifestations
Maria Luísa Cordeiro Santos, Breno Bittencourt de Brito, Filipe Antônio França da Silva, et al.
World Journal of Gastroenterology (2020) Vol. 26, Iss. 28, pp. 4076-4093
Open Access | Times Cited: 112
The Role of Diet in the Pathogenesis and Management of Inflammatory Bowel Disease: A Review
Gabrielle Wark, Dorit Samocha‐Bonet, Simon Ghaly, et al.
Nutrients (2020) Vol. 13, Iss. 1, pp. 135-135
Open Access | Times Cited: 99
Artificial intelligence in gastroenterology: A state-of-the-art review
Paul T. Kröner, Megan Engels, Benjamin S. Glicksberg, et al.
World Journal of Gastroenterology (2021) Vol. 27, Iss. 40, pp. 6794-6824
Open Access | Times Cited: 94
Intake of Ultra-processed Foods Is Associated with an Increased Risk of Crohn’s Disease: A Cross-sectional and Prospective Analysis of 187 154 Participants in the UK Biobank
Jie Chen, Judith Wellens, Rahul Kalla, et al.
Journal of Crohn s and Colitis (2022) Vol. 17, Iss. 4, pp. 535-552
Open Access | Times Cited: 65
Patients’ and professionals’ views related to ethical issues in precision medicine: a mixed research synthesis
Anke Erdmann, Christoph Rehmann‐Sutter, Claudia Bozzaro
BMC Medical Ethics (2021) Vol. 22, Iss. 1
Open Access | Times Cited: 59
Artificial intelligence and inflammatory bowel disease: Where are we going?
Leonardo Da Rio, Marco Spadaccini, Tommaso Lorenzo Parigi, et al.
World Journal of Gastroenterology (2023) Vol. 29, Iss. 3, pp. 508-520
Open Access | Times Cited: 37
Advancements in Inflammatory Bowel Disease: A Narrative Review of Diagnostics, Management, Epidemiology, Prevalence, Patient Outcomes, Quality of Life, and Clinical Presentation
Muhammad Ali Muzammil, Fnu Fariha, Tirath Patel, et al.
Cureus (2023)
Open Access | Times Cited: 29
A tissue atlas of ulcerative colitis revealing evidence of sex-dependent differences in disease-driving inflammatory cell types and resistance to TNF inhibitor therapy
Aaron T. Mayer, Derek Holman, Anav Sood, et al.
Science Advances (2023) Vol. 9, Iss. 3
Open Access | Times Cited: 28
Artificial intelligence & clinical nutrition: What the future might have in store
Ashley Bond, Kevin D. McCay, Simon Lal
Clinical Nutrition ESPEN (2023) Vol. 57, pp. 542-549
Closed Access | Times Cited: 28
Challenges in IBD Research 2024: Precision Medicine
Sana Syed, Brigid S. Boland, Lauren T Bourke, et al.
Inflammatory Bowel Diseases (2024) Vol. 30, Iss. Supplement_2, pp. S39-S54
Open Access | Times Cited: 10
Novel trends with biologics in inflammatory bowel disease: sequential and combined approaches
Giuseppe Privitera, Daniela Pugliese, Loris Riccardo Lopetuso, et al.
Therapeutic Advances in Gastroenterology (2021) Vol. 14
Open Access | Times Cited: 55
Thermo-sensitive hydrogel with mussel-inspired adhesion enhanced the non-fibrotic repair effect of EGF on colonic mucosa barrier of TNBS-induced ulcerative colitis rats through macrophage polarizing
Lifen Wang, Jiawei Xu, Pengpeng Xue, et al.
Chemical Engineering Journal (2021) Vol. 416, pp. 129221-129221
Closed Access | Times Cited: 44
Results of the Seventh Scientific Workshop of ECCO: Precision Medicine in IBD—What, Why, and How
Claudio Fiocchi, Gabriele Dragoni, Dimitrios Iliopoulos, et al.
Journal of Crohn s and Colitis (2021) Vol. 15, Iss. 9, pp. 1410-1430
Open Access | Times Cited: 44
Characterisation of the Circulating Transcriptomic Landscape in Inflammatory Bowel Disease Provides Evidence for Dysregulation of Multiple Transcription Factors Including NFE2, SPI1, CEBPB, and IRF2
Jan Krzysztof Nowak, Alex Adams, Rahul Kalla, et al.
Journal of Crohn s and Colitis (2022) Vol. 16, Iss. 8, pp. 1255-1268
Open Access | Times Cited: 33
Research hotspot and trend analysis in the diagnosis of inflammatory bowel disease: A machine learning bibliometric analysis from 2012 to 2021
Chuan Liu, Rong Yu, Jixiang Zhang, et al.
Frontiers in Immunology (2022) Vol. 13
Open Access | Times Cited: 30
IL23R-specific CAR Tregs for the treatment of Crohn’s disease
Yue Cui, Marion David, Laura Bouchareychas, et al.
Journal of Crohn s and Colitis (2024)
Closed Access | Times Cited: 8
N-glycans as functional effectors of genetic and epigenetic disease risk
Tamara Štambuk, Marija Klasić, Vlatka Zoldoš, et al.
Molecular Aspects of Medicine (2020) Vol. 79, pp. 100891-100891
Closed Access | Times Cited: 49
Tumour necrosis factor inhibitors in inflammatory bowel disease: the story continues
Laurent Peyrin‐Biroulet, William J. Sandborn, Remo Panaccione, et al.
Therapeutic Advances in Gastroenterology (2021) Vol. 14
Open Access | Times Cited: 41
Omics and Multi-Omics in IBD: No Integration, No Breakthroughs
Claudio Fiocchi
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 19, pp. 14912-14912
Open Access | Times Cited: 15
Revolutionizing Gastrointestinal Disorder Management: Cutting-Edge Advances and Future Prospects
C. Raman Suri, Babita Pande, Tarun Sahu, et al.
Journal of Clinical Medicine (2024) Vol. 13, Iss. 13, pp. 3977-3977
Open Access | Times Cited: 6
A Bivalent Aptamer-Based DNA Agonist for EGFR Signaling Effectively Alleviates Ulcerative Colitis In Vivo
Yulin Cong, Kun Liu, Zihong Huang, et al.
ACS Chemical Biology (2024) Vol. 19, Iss. 6, pp. 1280-1290
Closed Access | Times Cited: 5
Faecal microbiota signatures of IBD and their relation to diagnosis, disease phenotype, inflammation, treatment escalation and anti-TNF response in a European Multicentre Study (IBD-Character)
Simen Vatn, Adam Carstens, Anja Bråthen Kristoffersen, et al.
Scandinavian Journal of Gastroenterology (2020) Vol. 55, Iss. 10, pp. 1146-1156
Open Access | Times Cited: 37
Precision medicine and drug optimization in adult inflammatory bowel disease patients
Sophie Vieujean, Édouard Louis
Therapeutic Advances in Gastroenterology (2023) Vol. 16
Open Access | Times Cited: 12
Nanoparticle-mediated gene therapy strategies for mitigating inflammatory bowel disease
Priyanka Verma, Aasheesh Srivastava, Chittur V. Srikanth, et al.
Biomaterials Science (2020) Vol. 9, Iss. 5, pp. 1481-1502
Closed Access | Times Cited: 30
How to Choose the Biologic Therapy in a Bio-naïve Patient with Inflammatory Bowel Disease
Viviana Laredo, Carla J. Gargallo-Puyuelo, Fernando Gomollón
Journal of Clinical Medicine (2022) Vol. 11, Iss. 3, pp. 829-829
Open Access | Times Cited: 18
Page 1 - Next Page

Scroll to top